Graeme M. Greenfield
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The impact of JAK2V617F variant allele frequency in MPN patients following PEGylated interferon alpha discontinuation.
Journal: British journal of haematology
Published: June 27, 2025
Molecular pathogenesis of the myeloproliferative neoplasms.
Journal: Journal of hematology & oncology
Published: April 21, 2021
Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms.
Journal: Cancers
Published: August 20, 2020
Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort.
Journal: Journal of clinical pathology
Published: March 13, 2020
Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat.
Journal: Experimental hematology
Published: January 23, 2019
Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
Journal: British journal of haematology
Published: December 27, 2018
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms.
Journal: Journal of translational medicine
Published: November 01, 2018
Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia.
Journal: BMC hematology
Published: September 26, 2018
Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms - long term follow-up of a regional case series.
Journal: Thrombosis journal
Published: August 03, 2018
Last Updated: 09/26/2026